GlassScriptPhysician profile
Suken A Shah
NPI 1932291788
$2,136,540.17
in general payments reported to CMS, 2019-2025
29 companies · $264K in 2025
The $264K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554K · 2020: $472K · 2021: $340K · 2022: $183K · 2023: $176K · 2024: $148K · 2025: $264K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $344K · Consulting Fee: $210K · Travel and Lodging: $14K · Grant: $10K · Food and Beverage: $9,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $343,675.17 |
| Consulting Fee | $210,126.08 |
| Travel and Lodging | $14,159.92 |
| Grant | $10,000.00 |
| Food and Beverage | $9,625.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $876,103.60 | 2019-2025 | Trialtis, Dermabond, Velys |
| Medical Device Business Services, INC. | $444,438.01 | 2019-2025 | Dermabond, Stratafix, Expedium |
| Stryker Corporation | $342,245.82 | 2019-2025 | Nile Alternative Fixation System, N/A, Capri Corpectomy Cage System |
| Globus Medical, INC. | $339,082.23 | 2019-2025 | Reflect/Reflect Hde, Reflect, Excelsiusgps Robotic Navigation System |
| Pacira Pharmaceuticals Incorporated | $41,597.00 | 2020-2025 | Exparel, Iovera, Zilretta |
| Vb Spine LLC | $27,980.26 | 2025 | Cascadia Interbody System |
| Ethicon INC. | $16,185.00 | 2022-2024 | Dermabond, Stratafix |
| Orthofix Medical, INC. | $10,154.55 | 2023-2025 | 7d Surgical System, Mariner Deformity |
| Depuy Synthes Sales INC. | $9,575.32 | 2019-2025 | Dermabond, Expedium, Velys |
| Prosidyan, INC | $7,920.00 | 2021 | |
| Bioventus LLC | $7,110.20 | 2022 | |
| Zimvie INC. | $4,880.21 | 2023 | |
| Misonix INC | $2,400.00 | 2020 | |
| Biedermann Motech, INC. | $1,015.07 | 2021-2023 | Moss Vrs Spinal System |
| Orthopediatrics Corp. | $959.09 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $835.55 | 2019 | |
| Medtronic, INC. | $791.46 | 2023-2025 | Cd Horizon Spinal System |
| Alphatec Spine, INC | $751.08 | 2023-2025 | Invictus Open, Safeop, Lif |
| Nuvasive, INC. | $748.16 | 2019-2022 | |
| Wishbone Medical INC. | $450.00 | 2019 | |
| Highridge Medical LLC | $280.86 | 2024-2025 | Spine-None, The Tether |
| Medtronic USA, INC. | $225.44 | 2019 | |
| Ebi, LLC | $180.56 | 2025 | |
| Zimmer Biomet Holdings, INC. | $144.68 | 2019 | |
| Baxter Healthcare | $124.27 | 2024-2025 | Floseal |
| Biocomposites INC | $110.35 | 2022 | |
| Kuros Biosciences USA, INC | $95.24 | 2023 | |
| Davol INC. | $92.56 | 2023 | Arista Ah Flexitip |
| Genzyme Corporation | $63.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suken Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.